Search Results - "Teicher, E."

Safety and Efficacy of Raltegravir in HIV‐Infected Transplant Patients Cotreated with Immunosuppressive Drugs by Tricot, L., Teicher, E., Peytavin, G., Zucman, D., Conti, F., Calmus, Y., Barrou, B., Duvivier, C., Fontaine, C., Welker, Y., Billy, C., De Truchis, P., Delahousse, M., Vittecoq, D., Salmon‐Céron, D.

“…Solid organ transplantations (SOT) are performed successfully in selected HIV‐infected patients. However, multiple and reciprocal drug–drug interactions are…”
Get full text

Fibrosing Cholestatic Hepatitis in HIV/HCV Co‐Infected Transplant Patients—Usefulness of Early Markers After Liver Transplantation by Antonini, T. M., Sebagh, M., Roque‐Afonso, A. M., Teicher, E., Roche, B., Sobesky, R., Coilly, A., Vaghefi, P., Adam, R., Vittecoq, D., Castaing, D., Samuel, D., Duclos‐Vallée, J.‐C.

“…We characterized fibrosing cholestatic hepatitis (FCH) in a large cohort of HIV/HCV co‐infected patients. Between 1999 and 2008, 59 HIV infected patients were…”
Get full text

P0837 : Efficacy of sofosbuvir and daclatasvir in HIV/HCV co-infected patients with advanced fibrosis by Antonini, T.M, Bedoya, J. Ursic, Teicher, E, Coilly, A, de Martin, E, Roque-Afonso, A.-M, Quertainmont, Y, Goujard, C, Delfraissy, J.-F, Vittecoq, D, Samuel, D, Duclos-Vallee, J.-C

Get full text

P0737 : Meld score kinetics and survival in HIV/HCV patients: The ANRS EP 25 prethevic cohort by Gelu-Simeon, M, Bayan, T, Ostos, M, Boufassa, F, Steyaert, J.-M, Bertucci, I, Teicher, E, Anty, R, Pageaux, G.-P, Meyer, L, Duclos-Vallee, J.-C

Get full text

P1237 ANTI-HEPATITIS C (HCV) TRIPLE THERAPY WITH PROTEASE INHIBITORS IN HIV/HCV CO-INFECTED PATIENTS AFTER LIVER TRANSPLANTATION by Antonini, T.M, Furlan, V, Teicher, E, Haim-Boukobza, S, Sebagh, M, Coilly, A, Bonhomme-Faivre, L, Roque-Afonso, A.-M, Vittecoq, D, Samuel, D, Taburet, A.-M, Duclos-Vallee, J.-C

Get full text

Ledipasvir/Sofosbuvir in NS3/4A Protease Inhibitor-Experienced Subjects with HCV Genotype 1 and HIV-Co-Infection Final Results of the ANRS HC31 Softrih Study by Rosenthal, E, Fougerou-Leurent, C, Renault, A, Teicher, E, Dominguez, S, Naqvi, A, Metivier, S, Cotte, L, Reynes, J, Valantin, M.-A, Leroy, V, Pageaux, G.-P, Pol, S, Piroth, L, Perre, P, Morlat, P, Salmon-Ceron, D, Chas, J, Jeantils, V, de Truchis, P, Allègre, T, Dupon, M, Raffi, F, Yazdanpanah, Y, Poizot-Martin, I, Neau, D, Girard, P.-M, Zucman, D, Garraffo, R, Chevaliez, S, Carrieri, P, Aumaitre, H, Lacombe, K, Bailly, F, Billaud, E, Pailhé, A, Amri, I, Bourlière, M, Bellissant, E, Molina, J.-M

Get full text

Very prolonged liposomal amphotericin B use leading to a lysosomal storage disease by Michot, J.M, Gubavu, C, Fourn, E, Maigne, G, Teicher, E, Angoulvant, A, Blanche, S, Lortholary, O, Coilly, A, Duclos-Vallée, J.C, Sebagh, M, Guettier, C, Aumont, C, Delfraissy, J.F, Lambotte, O

“…Abstract Amphotericin B is a powerful polyene antifungal drug used for treating systemic fungal infections and is usually administered for a short period. Side…”
Get full text

991 ACUTE LIVER FAILURE IN HIV INFECTED PATIENTS: A SINGLE CENTER EXPERIENCE by Antonini, T.M, Vinaixa, C, Ichai, P, Sebagh, M, Haim- Boukobza, S, Teicher, E, Coilly, A, Roque-Afonso, A.-M, Roche, B, Vibert, E, Adam, R, Castaing, D, Duclos-Vallee, J.-C, Samuel, D

Get full text

Infectious complications after liver transplantation in human immunodeficiency virus-infected recipients by Teicher, E., Boufassa, F., Vittecoq, D., Antonini, T.M., Tateo, M.-G., Coilly, A., Roque-Afonso, A.-M., Kassis-Chikhani, N., Lambotte, O., Ichai, P., Samuel, D., Duclos-Vallee, J.-C.

“…Background Few studies have investigated infections in human immunodeficiency virus (HIV)‐infected liver transplant patients. The aim of this study was to…”
Get full text

140 IMPACT OF SARCOPENIA ON MORTALITY AFTER LIVER TRANSPLANTATION IN HIV INFECTED PATIENTS by Antonini, T.M, Ciacio, O, Bucur, P, Bivol, S, Coilly, A, Ichai, P, Pittau, G, Teicher, E, Roque-Afonso, A.-M, Sa Cunha, A, Adam, R, Castaing, D, Samuel, D, Duclos-Vallee, J.-C, Vibert, E

Get full text

495 ARE LIVER TRANSPLANT HIV-1 INFECTED PATIENTS AT RISK TO DEVELOP HIV-1 DRUG RESISTANCE? by Teicher, E, Desbois, D, Dussaix, E, Figueroa, M, Antonini, T, Duclos Vallée, J.-C, Samuel, D, Vittecoq, D

Get full text

464 CHARACTERISTICS AND PROGNOSIS OF FIBROSING CHOLESTATIC HEPATITIS AFTER LIVER TRANPLANTATION IN A LARGE COHORT OF HIV/HCV CO-INFECTED PATIENTS by Antonini, T.M, Sebagh, M, Roque-Afonso, A.-M, Teicher, E, Roche, B, Azoulay, D, Adam, R, Vittecoq, D, Castaing, D, Samuel, D, Duclos-Vallee, J.-C

Get full text

[154] SURVIVAL ANALYSIS OF HIV INFECTED PATIENTS REFERRED TO A LIVER TRANSPLANT UNIT by Duclos-Vallee, J.C, Delvart, V, Blandin, F, Teicher, E, Antonini, T, Azoulay, D, Roche, B, Saliba, F, Ichai, P, Adam, R, Castaing, D, Vittecoq, D, Samuel, D

Get full text

459 ANALYSE OF PREDICTIVE FACTORS OF MORTALITY OF HIV/HCV INFECTED PATIENTS ON THE WAITING LIST OF LIVER TRANSPLANTATION by Carmona, D, Delvart, V, Antonini, T.M, Sobesky, R, Roche, B, Teicher, E, Vittecoq, D, Adam, R, Azoulay, D, Castaing, D, Samuel, D, Duclos-Vallée, J.-C

Get full text

Infective endocarditis caused by Streptococcus sinensis by Seta, V, Teicher, E, Fortineau, N, Ladouceur, M, Lambotte, O

Get full text

CALCOFLUOR AS A FLUORESCENT PROBE TO DETECT BIOFILMS OF FOODBORNE PATHOGENS by DE REZENDE, C.L. ERIKSSON, JOSEPH, S.W., TEICHER, E., CARR, L.E., TALL, B., WEINER, R.M.

“…ABSTRACT Biofilms enable foodborne pathogens to resist removal from surfaces, survive disinfection and elude detection. This study evaluated the use of…”
Get full text

Boosted protease inhibitor monotherapy as a maintenance strategy: an observational study by GUIGUET, Marguerite, GHOSN, Jade, COSTAGLIOLA, Dominique, DUVIVIER, Claudine, MEYNARD, Jean-Luc, GRAS, Guillaume, PARTISANI, Marialuisa, TEICHER, Elina, MAHAMAT, Aba, RODENBOURG, Franck, LAUNAY, Odile

“…We aimed to determine the effectiveness of boosted protease inhibitor monotherapy (BPIMT) initiated as a maintenance strategy in routine care and identify…”
Get full text

Pharmacokinetic Study of Raltegravir in HIV-Infected Patients With End-Stage Liver Disease: The LIVERAL-ANRS 148 Study by Barau, Caroline, Braun, Joséphine, Vincent, Corine, Haim-Boukobza, Stéphanie, Molina, Jean-Michel, Miailhes, Patrick, Fournier, Isabelle, Aboulker, Jean-Pierre, Vittecoq, Daniel, Duclos-Vallée, Jean-Charles, Taburet, Anne-Marie, Teicher, Elina

“…Background. The end-stage LIVER disease and RALtegravir-Agence Nationale de Recherche sur le Sida et les hépatites (LIVERAL-ANRS) 148 study aimed to evaluate…”
Get full text

Efficacy, safety and patient‐reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor‐experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study) by Rosenthal, E, Fougerou‐Leurent, C, Renault, A, Carrieri, MP, Marcellin, F, Garraffo, R, Teicher, E, Aumaitre, H, Lacombe, K, Bailly, F, Billaud, E, Chevaliez, S, Dominguez, S, Valantin, MA, Reynes, J, Naqvi, A, Cotte, L, Metivier, S, Leroy, V, Dupon, M, Allegre, T, De Truchis, P, Jeantils, V, Chas, J, Salmon‐Ceron, D, Morlat, P, Neau, D, Perré, P, Piroth, L, Pol, S, Bourlière, M, Pageaux, GP, Alric, L, Zucman, D, Girard, PM, Poizot‐Martin, I, Yazdanpanah, Y, Raffi, F, Pabic, E Le, Tual, C, Pailhé, A, Amri, I, Bellissant, E, Molina, JM, Gérard, Laurence, Duvivier, Claudine, Lafeuillade, Alain, Batisse, Dominique, Mortier, Emmanuel, Simon, Anne, Makhloufi, Djamila, Michelet, Christian, Cheret, Antoine, May, Thierry, Moreau, Jacques, Ledinghen, Victor, Rosa, Isabelle, Ahmim, Mustapha, Raimon, Julie, Thierry, Régine, Martin, Amélie

“…Objectives Studies evaluating the efficacy and safety of the fixed‐dose combination ledipasvir (LDV)/sofosbuvir (SOF) in patients coinfected with HIV‐1 and…”
Get full text

Toxicité des antirétroviraux chez les patients co-infectés par les virus VIH et VHC by Roser, F., Soyer, A., Duclos-Vallée, J.-C., Teicher, E., Sebagh, M., Azoulay, D., Samuel, D., Vittecoq, D., Lemoine, A.

“…L'apparition des HAART ( highly active antiretroviral therapy), a profondément modifié les données épidémiologiques de l'infection par le VIH. En conséquence,…”
Get full text